THERAPEUTIC EXPERTISE
Comprehensive Clinical Expertise and Regulatory Success
For the past decade, we have delivered over 150 Phase I-IV clinical study analyses with 15+ drug approval records in oncology, GI, rare diseases, gene therapy, CNS, vaccines, and many challenging therapeutic areas. We specialize in complex studies, submission support, rapid turnaround projects, and rescue operations.
Oncology
- Leukemia (ALL, AML, CML, etc)
- Multiple Myeloma (MM)
- Lymphoma
- Myelodysplastic Syndrome (MDS)
- Systemic Mastocytosis (SM)
- Lung Cancer (NSCLC)
- Gastrointestinal Stromal Tumors
Gastroenterology
- Eosinophilic Esophagitis
- Inflammatory Bowel Disease (IBD)
- Ulcerative Colitis and Crohn’s Disease
- Liver Disease
Rare Disease & Gene Therapy
- Gaucher Disease
- Fabry Disease
- Hunter Syndrome
- Metachromatic Leukodystrophy (MLD)
- DMD, LGMD
- Studies overlap with other therapeutic areas like SM, HAE
Hematology
- Thrombotic Thrombocytopenic Purpura (TTP)
- Hemophilia, von Willebrand disease (VWD)
- Rare Disorder of Mast Cells
Anti-Infectives
- Antiviral – CMV
- Studies overlap with Vaccines
Vaccine
- Influenza
- Dengue
- Zika
CNS and Psychiatry
- Schizophrenia
- ADHD
Immunology
- Graft Versus Host Disease (GVHD)
- Lupus
- Immunodeficiency (HAE)
- Studies overlap with other therapeutic areas like Vaccines (Dengue, Influenza), Inflammation (IBD)
Get in touch
Have you found what you’re looking for? If not, our team is here to help. Discover more about our services and how we can tailor them to meet your needs.
Contact
